The Impact of Prescribing Guidelines on Physician Selection of Drug Therapy for Newly Diagnosed Patients with Hypertension in the UK

Aug-10

AUTHORS : Prof Rachel Elliott (Details for study: Harvard Pilgrim Healthcare Institute/Harvard Medical School) now works at: Division of Population Health, Health Services Research & Primary Care, University of Manchester, Oxford Rd, Manchester M13 9PL, UK – Email: rachel.a.elliott@manchester.ac.uk – Profile: https://www.research.manchester.ac.uk/portal/rachel.a.elliott.html

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):147

DOI : 10.1002/pds.2019

The Impact of Prescribing Guidelines on Physician Selection of Drug Therapy for Newly Diagnosed Patients with Hypertension in the UK

More publications

The risk of immune-mediated inflammatory diseases following exposure to childhood maltreatment: a retrospective cohort study using UK primary care data

A double-Cox model for non-proportional hazards survivalanalysis with frailty

Regression discontinuity designs for time-to-event outcomes: An approach using accelerated failure time models